Lithium bis(trimethylsilyl)amide

T&W Group was established in 2007 and is headquartered in Shanghai. Its subsidiaries are located in Shanghai, Hebei and Shandong. By pooling talent, technology, and potential, we are committed to creating value for our customers and contributing to a better life. Our business involves biomedicine, fine chemicals and industrial investment, including: -Process development, commercial production and customized production of APIs, pharmaceutical intermediates, and fine chemicals; -Outsourcing procurement and agency sales of pharmaceutical chemicals; -Incubation and investment of high-tech and enterprises in the fields of medicine, biology and chemical industry. The company has 1,500 square meters of R&D centers in Shanghai and Shijiazhuang. Among them, there are two kilogram laboratories with a reactor volume from 10 to 100 liters, which can simultaneously carry out process development and pilot scale-up production of multiple projects. Our scientific research management team is composed of experienced doctors, and has international advanced analysis and detection equipment, as well as high-speed and convenient literature database access. The company's cGMP production base is located in Jiangsu, covering an area of 150 acres. Including ten GMP production lines, with flexible productivity in compliance with cGMP standards, zero defects passed the on-site inspection by the US FDA. Mainly in the production of APIs and advanced pharmaceutical intermediates and customized production services. An intermediate production base is located in Shandong, covering an area of ??270 acres, mainly for the production and customized production of pharmaceutical intermediates and fine chemicals. After years of development, the company has established stable cooperative relations with many domestic and foreign pharmaceutical and chemical companies. Customers see T&W as a trusted long-term strategic partner. In order to better meet customer procure.